OWLT:NYE-Owlet Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 4.52

Change

+0.04 (+0.89)%

Market Cap

USD 0.08B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.13 (-0.20%)

USD 10.78B
DOCS Doximity Inc

+0.17 (+0.32%)

USD 10.37B
WEAV Weave Communications Inc

-0.23 (-1.44%)

USD 1.13B
MPLN MultiPlan Corporation

-1.83 (-12.38%)

USD 0.12B
AMWL American Well Corp

-0.21 (-2.90%)

USD 0.11B
PHR Phreesia Inc

+0.03 (+0.12%)

N/A
VEEV Veeva Systems Inc Class A

+0.33 (+0.16%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

+0.24 (+2.13%)

N/A
TDOC Teladoc Inc

+0.43 (+4.73%)

N/A

ETFs Containing OWLT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.39% 45% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.39% 45% F 14% F
Trailing 12 Months  
Capital Gain -14.39% 45% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.39% 45% F 14% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.93% 82% B 81% B-
Dividend Return 20.93% 82% B 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 289.08% 9% A- 4% F
Risk Adjusted Return 7.24% 64% D 25% F
Market Capitalization 0.08B 8% B- 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector